Prospective comparison of discrimination algorithms to prevent inappropriate ICD therapy: primary results of the Rhythm ID Going Head to Head Trial.

BACKGROUND Inappropriate therapy for supraventricular arrhythmias remains a significant source of morbidity in implantable cardioverter-defibrillator (ICD) recipients. OBJECTIVE The Rhythm ID Goes Head to Head Trial (RIGHT) was designed to compare rhythm discrimination and inappropriate therapies among patients with ICDs from 2 manufacturers. METHODS Patients with standard ICD indications were randomized to receive a Guidant VITALITY 2 with Rhythm ID or selective Medtronic pulse generators using the Enhanced PR Logic or Wavelet discrimination algorithms. A single- or dual-chamber device was implanted based on clinical indications and programmed in 2 detection zones with detection enhancements enabled for rates between 150 and 200 bpm. Algorithm performance was compared between randomization groups, stratified by single or dual chamber, for the primary end point of first inappropriate therapy (shock or antitachycardia pacing) for supraventricular arrhythmias. RESULTS There were 1962 patients enrolled and followed for 18.3 ± 9.2 months, with no difference in all-cause mortality between groups. There were 3973 treated episodes where electrograms were available and adjudicated. The primary end point of inappropriate therapy occurred in 246 of 985 VITALITY 2 patients vs 187 of 977 specific Medtronic ICD patients (hazard ratio = 1.34; confidence interval = 1.11-1.62; P = .003). Differences in inappropriate therapy were confined to single-chamber ICDs. Inappropriate shocks were more frequent in VITALITY 2 ICDs (hazard ratio = 1.63; confidence interval = 1.29-2.06; P < .001), with most therapies and performance differences occurring at slower rhythms (rates < 175 bpm). CONCLUSION Rhythm discrimination performed better in the specific Medtronic than in VITALITY 2 ICDs evaluated, particularly for single-chamber devices. Inappropriate therapies, and differences in performance, may be reduced with the use of rate cutoff above 175 bpm.

[1]  N. Sheth,et al.  Detection of atrial fibrillation and flutter by a dual-chamber implantable cardioverter-defibrillator. For the Worldwide Jewel AF Investigators. , 2000, Circulation.

[2]  E. Fain,et al.  Comparison of (cid:1) -Blockers, Amiodarone Plus (cid:1) -Blockers, or Sotalol for Prevention of Shocks From Implantable Cardioverter Defibrillators The OPTIC Study: A Randomized Trial , 2005 .

[3]  Dick M. Goedhart,et al.  Prevention of inappropriate therapy in implantable cardioverter-defibrillators: results of a prospective, randomized study of tachyarrhythmia detection algorithms. , 2004, Journal of the American College of Cardiology.

[4]  D. Slotwiner,et al.  Frequent Recurrent Polymorphic Ventricular Tachycardia during Sleep Due to Managed Ventricular Pacing , 2009, Pacing and clinical electrophysiology : PACE.

[5]  C. Schmitt,et al.  Do Current Dual Chamber Cardioverter Defibrillators Have Advantages Over Conventional Single Chamber Cardioverter Defibrillators in Reducing Inappropriate Therapies? A Randomized, Prospective Study , 2001, Journal of cardiovascular electrophysiology.

[6]  M. Keller,et al.  A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. , 1997, The New England journal of medicine.

[7]  P. Kudenchuk,et al.  The DAVID (Dual Chamber and VVI Implantable Defibrillator) II trial. , 2009, Journal of the American College of Cardiology.

[8]  Joshua R. Smith,et al.  The Rhythm ID Going Head to Head Trial (RIGHT): Design of a Randomized Trial Comparing Competitive Rhythm Discrimination Algorithms in Implantable Cardioverter Defibrillators , 2006, Journal of cardiovascular electrophysiology.

[9]  Jeroen J. Bax,et al.  Inappropriate implantable cardioverter-defibrillator shocks: incidence, predictors, and impact on mortality. , 2011, Journal of the American College of Cardiology.

[10]  Jeffrey M. Gillberg,et al.  Critical analysis of dual-chamber implantable cardioverter-defibrillator arrhythmia detection : results and technical considerations. , 2001 .

[11]  Wojciech Zareba,et al.  Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact. , 2008, Journal of the American College of Cardiology.

[12]  M. Giudici,et al.  Clinical Results of an Advanced SVT Detection Enhancement Algorithm , 2005, Pacing and clinical electrophysiology : PACE.

[13]  P. Dorian,et al.  Continuous Template Collection and Updating for Electrogram Morphology Discrimination in Implantable Cardioverter Defibrillators , 2006, Pacing and clinical electrophysiology : PACE.

[14]  Arjun D. Sharma,et al.  Improving SVT Discrimination in Single‐Chamber ICDs: A New Electrogram Morphology‐Based Algorithm , 2006, Journal of cardiovascular electrophysiology.

[15]  Walter H Olson,et al.  Discrimination of Ventricular Tachycardia from Supraventricular Tachycardia by a Downloaded Wavelet‐Transform Morphology Algorithm: A Paradigm for Development of Implantable Cardioverter Defibrillator Detection Algorithms , 2002, Journal of cardiovascular electrophysiology.

[16]  Shibaji Shome,et al.  Improving contemporary algorithms for implantable cardioverter-defibrillator function. , 2010, Journal of electrocardiology.

[17]  Suneet Mittal,et al.  Do atrial tachyarrhythmias beget ventricular tachyarrhythmias in defibrillator recipients? , 2002, Journal of the American College of Cardiology.

[18]  M. Niebauer,et al.  Clinical Investigation of a New Dual‐Chamber Implantable Cardioverter Defibrillator with Improved Rhythm Discrimination Capabilities , 2003, Journal of cardiovascular electrophysiology.

[19]  D. Mark,et al.  Prognostic importance of defibrillator shocks in patients with heart failure. , 2008, The New England journal of medicine.

[20]  Stephen L Moore,et al.  Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study. , 2008, Journal of the American College of Cardiology.

[21]  R. van Mechelen,et al.  Risk of managed ventricular pacing in a patient with heart block. , 2006, Heart rhythm.

[22]  P. Heidenreich,et al.  Real World Evaluation of Dual‐Zone ICD and CRT‐D Programming Compared to Single‐Zone Programming: The ALTITUDE REDUCES Study , 2011, Journal of cardiovascular electrophysiology.

[23]  L. Jordaens,et al.  Prevention of inappropriate therapy in implantable defibrillators: A meta-analysis of clinical trials comparing single-chamber and dual-chamber arrhythmia discrimination algorithms. , 2008, International journal of cardiology.

[24]  Douglas L Packer,et al.  Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. , 2005, The New England journal of medicine.

[25]  J. Oss,et al.  PROPHYLACTIC IMPLANTATION OF A DEFIBRILLATOR IN PATIENTS WITH MYOCARDIAL INFARCTION AND REDUCED EJECTION FRACTION , 2002 .

[26]  M. Sweeney A novel cause of pacing-facilitated short-long-short onset sequence ventricular tachycardia in the DDD/R mode: what is the mechanism? , 2008, Heart rhythm.

[27]  Alain Ripart,et al.  Arrhythmia detection by dual-chamber implantable cardioverter defibrillators. A review of current algorithms. , 2004, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[28]  Zengri J. Wang,et al.  A comparison of empiric to physician-tailored programming of implantable cardioverter-defibrillators: results from the prospective randomized multicenter EMPIRIC trial. , 2006, Journal of the American College of Cardiology.